Greenfield, Indiana-based Elanco Animal Health, a pharmaceutical company specializing in the manufacture of medicines and vaccinations for pets and livestock, has announced a post-merger consolidation and cost-cutting plan to reduce its world headcount by 380 employees, including a 20% reduction of senior managers. Approximately 100 employees in Greenfield will be impacted.
The decision was driven by the company's post-merger acquisition of Bayer Animal Health which closed in August 2020. Previous announcements indicated that 900 employees in 40 countries would be impacted as its commercial operations for Elanco International and Elanco Europe were consolidated.
According to a company spokesperson, “While actions that impact our team are always difficult, it is imperative that we simplify our organization and focus on delivering customer value to meet our commitments to improve our profitability, even in the midst of increasing inflationary and supply chain costs.”
Change is coming. There will always be a tomorrow, no matter how much you may try to ignore it. There are no guarantees in life or promises for a bright future. Just because something bad hasn't happened yet, doesn't mean it won't. It can happen to anyone, anytime, anywhere. No one is guaranteed to wake up tomorrow and still have a job by evening. Are you now wondering, Am I Next?